These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 3180336)

  • 1. Summation effect of uracil on the two-stage and multistage models of urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Masui T; Shirai T; Takahashi S; Mutai M; Fukushima S
    Carcinogenesis; 1988 Nov; 9(11):1981-5. PubMed ID: 3180336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    de Camargo JL; Shirai T; Kato T; Asamoto M; Fukushima S
    Jpn J Cancer Res; 1991 Nov; 82(11):1220-5. PubMed ID: 1752781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong promoting activity of reversible uracil-induced urolithiasis on urinary bladder carcinogenesis in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Shirai T; Tagawa Y; Fukushima S; Imaida K; Ito N
    Cancer Res; 1987 Dec; 47(24 Pt 1):6726-30. PubMed ID: 3677102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoting activities of butylated hydroxyanisole and butylated hydroxytoluene on 2-stage urinary bladder carcinogenesis and inhibition of gamma-glutamyl transpeptidase-positive foci development in the liver of rats.
    Imaida K; Fukushima S; Shirai T; Ohtani M; Nakanishi K; Ito N
    Carcinogenesis; 1983; 4(7):895-9. PubMed ID: 6135514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoting effect of sodium chloride in 2-stage urinary bladder carcinogenesis in rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Shibata MA; Nakanishi K; Shibata M; Masui T; Miyata Y; Ito N
    Urol Res; 1986; 14(4):201-6. PubMed ID: 3787885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent effects of butylated hydroxyanisole, butylated hydroxytoluene and ethoxyquin for promotion of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats.
    Fukushima S; Ogiso T; Kurata Y; Hirose M; Ito N
    Cancer Lett; 1987 Jan; 34(1):83-90. PubMed ID: 3802071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of synergism in rat urinary tract carcinogenesis between prior uracil treatment and N-butyl-N-(4-hydroxybutyl)-nitrosamine administration.
    Okumura M; Shirai T; Asamoto M; Ogiso T; Fukushima S
    Cancer Lett; 1991 Jun; 58(1-2):81-5. PubMed ID: 2049787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trisodium nitriloacetate monohydrate: promoting effect in urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Hiasa Y; Kitahori Y; Konishi N; Shimoyama T; Miyashiro A
    J Natl Cancer Inst; 1985 Jan; 74(1):235-9. PubMed ID: 3855482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoting effect of the peroxisome proliferator, clofibrate, but not di(2-ethylhexyl)phthalate, on urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Hagiwara A; Tamano S; Ogiso T; Asakawa E; Fukushima S
    Jpn J Cancer Res; 1990 Dec; 81(12):1232-8. PubMed ID: 2125992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in Wistar rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Kitahori Y; Konishi N; Shimoyama T; Hiasa Y
    Jpn J Cancer Res; 1985 Sep; 76(9):818-22. PubMed ID: 3932279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemically demonstrated variation in expression of cathepsin E between uracil-induced papillomatosis and N-butyl-N-(4-hydroxybutyl)nitrosamine-induced preneoplastic and neoplastic changes in rat urinary bladder.
    Yamamoto S; Yonezawa S; Ichinose M; Miki K; Masui T; Fukushima S; Inoue H; Tatematsu M
    Virchows Arch; 1996 Mar; 427(6):589-94. PubMed ID: 8605570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoting effects of various agents in rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Kurata Y; Asamoto M; Hagiwara A; Masui T; Fukushima S
    Cancer Lett; 1986 Aug; 32(2):125-35. PubMed ID: 3756839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing effects of uracil-induced urolithiasis on amplification of second-stage promotion in rat bladder carcinogenesis.
    Shibata MA; Hasegawa R; Sano M; Shirai T; Fukushima S
    Jpn J Cancer Res; 1991 Oct; 82(10):1077-84. PubMed ID: 1659569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in cell proliferation and apoptosis between reversible and irreversible mucosal lesions associated with uracil-induced urolithiasis in N-butyl-N-(4-hydroxybutyl)nitrosamine-pretreated.
    Shirai T; Shibata M; Takahashi S; Tagawa Y; Imaida K; Hirose M
    Carcinogenesis; 1995 Mar; 16(3):501-5. PubMed ID: 7697805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Salim EI; Wanibuchi H; Morimura K; Kim S; Yano Y; Yamamoto S; Fukushima S
    Carcinogenesis; 2000 Feb; 21(2):195-203. PubMed ID: 10657958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting effects of diethylmaleate or NH4Cl on NaHCO3, but not butylated hydroxyanisole, promotion of urinary bladder carcinogenesis in male F344 rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Hagiwara A; Tanaka H; Tamano S; Imaida K; Takahashi S; Fukushima S
    J Toxicol Sci; 1994 Nov; 19(4):189-95. PubMed ID: 7884829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose response of saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Nakanishi K; Hagiwara A; Shibata M; Imaida K; Tatematsu M; Ito N
    J Natl Cancer Inst; 1980 Nov; 65(5):1005-10. PubMed ID: 6933236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of quercetin on two-stage carcinogenesis of the rat urinary bladder.
    Hirose M; Fukushima S; Sakata T; Inui M; Ito N
    Cancer Lett; 1983 Nov; 21(1):23-7. PubMed ID: 6640511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summation and synergism in the promotion of urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)-nitrosamine in F344 rats.
    Sakata T; Shirai T; Fukushima S; Hasegawa R; Ito N
    Gan; 1984 Nov; 75(11):950-6. PubMed ID: 6519396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of epithelial proliferation revealed by continuous administration of bromodeoxyuridine during urinary bladder carcinogenesis in rats.
    Tatematsu M; Fukushima S; Aoki T; Mera Y; Inoue T; Ito N
    Jpn J Cancer Res; 1987 Sep; 78(9):879-82. PubMed ID: 3117745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.